854515-52-9 Usage
Uses
Used in Medicinal Chemistry:
6-Hydroxy-2-methylbenzofuran-3-carboxylic acid is used as a pharmaceutical precursor for the development of new drugs, leveraging its structural features and potential pharmacological properties. Its benzofuran framework has been associated with a range of biological activities, making it a promising candidate for further exploration in drug discovery.
Used in Organic Synthesis:
In the field of organic synthesis, 6-Hydroxy-2-methylbenzofuran-3-carboxylic acid serves as a versatile intermediate. Its carboxylic acid group allows for various chemical reactions, facilitating the creation of a wide array of derivative compounds with potential applications in different industries.
Used in Chemical Research:
6-Hydroxy-2-methylbenzofuran-3-carboxylic acid is utilized as a subject of study in chemical research to understand its reactivity, stability, and the influence of its substituents on its properties. This research can lead to insights that are valuable for the development of new synthetic methods and applications.
While the provided materials do not specify particular industries or detailed applications beyond medicinal chemistry and organic synthesis, the compound's versatility suggests potential uses in various sectors, such as pharmaceuticals, agrochemicals, or materials science, pending further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 854515-52-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,4,5,1 and 5 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 854515-52:
(8*8)+(7*5)+(6*4)+(5*5)+(4*1)+(3*5)+(2*5)+(1*2)=179
179 % 10 = 9
So 854515-52-9 is a valid CAS Registry Number.
854515-52-9Relevant academic research and scientific papers
Synthetic method of VEGFR inhibitor furoquitinib and benzofuran intermediate thereof
-
Paragraph 0087-0089, (2021/05/01)
The invention discloses a synthetic method of a VEGFR inhibitor furoquitinib and a benzofuran intermediate thereof. The synthetic method of the VEGFR inhibitor furoquitinib comprises the following steps of S1, halogenation, S2, acylation, S3, coupling, S4
COMPOUNDS AND METHODS FOR MODULATING FXR
-
Page/Page column 27, (2008/06/13)
Compounds of formula. wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and related diseases.
